Lung Cancer
Conditions
Interventions
Ropivacaine blockade group:Thoracic sympathetic trunk nerve ropivacaine block
Sponsors
Yantai Yuhuangding Hospital
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients with ASA grade I-III; 2.aged 30-80 years; 3.Signed informed consent; 4.Patients who are scheduled to undergo elective thoracoscopic radical resection of lung cancer;
Exclusion criteria
Exclusion criteria: 1.Has a known history of allergy to the anesthetic agents used in the study (such as ropivacaine) or other related drugs. 2.Autonomic dysfunction; 3.Mental dysfunction or psychiatric disorders; 4.Patients with severe cardiovascular disease, such as heart failure, coronary arteriosclerotic heart disease, severe valvular stenosis or insufficiency, cardiomyopathy, high-grade atrioventricular block, and atrial fibrillation; 5.Hepatic and renal insufficiency; 6.Long-term use of opioids; 7.Difficulty communicating;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MDASI-LC;QoR-15;Bauer questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS;COR;heart rate;Intraoperative perioperative analgesic drugs (opioids, NSAIDs, etc.);IL-6;CRP;MAP;Vasoactive drugs;rate-pressure product,RPP;Fasting blood glucose; | — |
Countries
China
Contacts
Public ContactShi Cunxian
Yantai Yuhuangding Hospital
Outcome results
None listed